Sunday, February 24, 2013


Lupin looks a strong buy in pharma sector and also a portfolio stock.
Lupin recently posted robust earnings with consolidated net profit grew by 42.6%.

Technically stock is moving in an upward trending channel. Also there is a sub channel inside that upward trending channel.

Short term:
Short term targets could be 608/624. Crossing 626 stock may go to 684 in March 2013.
Trade with short term SL at 575.

Long Term:
For Portfolio investors, keep accumulate the stock below 600 with deep SL at 535 for a target above 760.

Chart enclosed. 

No comments:

Post a Comment